Information card for entry 2020314
Chemical name
(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-5-Allyl-2-[(<i>S</i>)-2,3-dihydroxypropyl]-4-[(phenylsulfonyl)methyl]tetrahydrofuran-3-ol
Formula
C17 H24 O6 S
Calculated formula
C17 H24 O6 S
SMILES
S(=O)(=O)(C[C@@H]1[C@@H](O)[C@H](O[C@H]1CC=C)C[C@H](O)CO)c1ccccc1
Title of publication
Structural corroboration of two important building blocks of the anticancer drug eribulin mesylate through two-dimensional NMR and single-crystal X-ray diffraction studies
Authors of publication
Pullela, Srinivas Venkata; Acharya, Vinod; Reddy, Nagarjuna; Harlikar, Jayvant; Kulkarni, Amar; Chavan, Rakesh; Yadav, Ajay; Manna, Shuvendu; Ghosh, Angshuman
Journal of publication
Acta Crystallographica Section C
Year of publication
2016
Journal volume
72
Journal issue
1
Pages of publication
14 - 20
a
7.593 ± 0.006 Å
b
8.542 ± 0.007 Å
c
26.7 ± 0.02 Å
α
90°
β
90°
γ
90°
Cell volume
1732 ± 2 Å3
Cell temperature
200 K
Ambient diffraction temperature
200 K
Number of distinct elements
4
Space group number
19
Hermann-Mauguin space group symbol
P 21 21 21
Hall space group symbol
P 2ac 2ab
Residual factor for all reflections
0.0358
Residual factor for significantly intense reflections
0.033
Weighted residual factors for significantly intense reflections
0.0804
Weighted residual factors for all reflections included in the refinement
0.0821
Goodness-of-fit parameter for all reflections included in the refinement
1.048
Diffraction radiation wavelength
0.71075 Å
Diffraction radiation type
MoKα
Has coordinates
Yes
Has disorder
No
Has Fobs
Yes
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/2020314.html